Welcome to our dedicated page for Fuller H B Co SEC filings (Ticker: FUL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking H.B. Fuller’s adhesive empire means parsing dense pages on resin costs, energy surcharges, and safety regulations across five continents. Each new 10-K or 8-K layers chemical terminology over sprawling segment tables, prompting many investors to ask, “How can I start understanding H.B. Fuller SEC documents with AI?”
Stock Titan solves that problem. Our platform ingests every submission the moment it hits EDGAR, then delivers plain-English insights you can act on. Need the packaging division’s margin trend from the latest H.B. Fuller quarterly earnings report 10-Q filing? It’s summarised in seconds. Waiting for an alert on executive trades? We flag H.B. Fuller insider trading Form 4 transactions the instant they post, linking each trade to H.B. Fuller 8-K material events explained right below. Environmental footnotes, foreign-currency impacts, or pension assumptions—our AI-powered summaries turn technical prose into clarity.
Below, every form is ready for download or instant AI review—from the H.B. Fuller annual report 10-K simplified to the latest proxy statement executive compensation tables. Investors rely on this hub to:
- Monitor H.B. Fuller Form 4 insider transactions real-time before earnings calls
- Compare adhesive segment growth with H.B. Fuller earnings report filing analysis
- Track H.B. Fuller executive stock transactions Form 4 alongside cash-flow swings
The result: H.B. Fuller SEC filings explained simply, updated in real time, and enriched with expert context—so you never miss the data that drives decisions.
Teresa J. Rasmussen Trangsrud, a director of H.B. Fuller Co. (FUL), reported transactions dated 08/29/2025. The filing shows a disposal of 2,343 shares of common stock and the acquisition of 968.47 stock units under the Directors' Deferred Compensation Plan. The stock units convert 1-for-1 into common shares upon specified events and include units received as dividend equivalents. After these transactions, the reporting person beneficially owns 18,556.15 shares (direct ownership). The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Charles T. Lauber, a director of H.B. Fuller Company (FUL), reported Form 4 transactions dated 08/29/2025. The filing shows non-derivative and derivative stock-unit activity. On 08/29/2025 he acquired 450.45 stock units (treated as common stock on a 1-for-1 basis) at a reported price basis of $61.05, bringing his beneficial ownership in that class to 9,485.99 units. The filing also reports 1,346.071 restricted stock units that convert 1-for-1 into common stock with a listed conversion/exercise date of 01/24/2026, and the same amount is shown as beneficially owned following the transaction. The units include amounts credited via a dividend equivalent feature of the Directors' Deferred Compensation Plan and some units convert upon retirement, death, disability, or specified events, subject to holding requirements. The form is signed by an attorney-in-fact on 09/02/2025.
Ruth Kimmelshue, a director of H.B. Fuller Company (FUL), reported transactions on August 29, 2025. She disposed of 1,351 shares of common stock and acquired 529.28 stock units under the Directors' Deferred Compensation Plan. The stock units convert 1-for-1 into common shares upon retirement, death, disability or specified events and include dividend-equivalent units. After these transactions, the filing reports beneficial ownership of 32,044.46 shares. The Form 4 was submitted by an attorney-in-fact and signed on September 2, 2025.
Michael J. Happe, a director of H.B. Fuller Company (FUL), reported transactions on 08/29/2025. He disposed of 1,343 shares of common stock. The filing also reports acquisition of 450.45 stock units under the Directors' Deferred Compensation Plan that convert 1-for-1 into common shares and will convert on retirement, death, disability or certain specified events, subject to holding periods. The reported holdings after the transactions equal 13,390.71 shares beneficially owned, which includes stock units credited as dividend equivalents. The form was signed by an attorney-in-fact on 09/02/2025.
H.B. Fuller director Thomas W. Handley reported changes in beneficial ownership dated 08/29/2025. The filing shows a disposition of 1,347.1 shares of common stock and the acquisition of 540.54 stock units under the Directors' Deferred Compensation Plan. Those units convert 1-for-1 into common shares and will convert upon retirement, death, disability or certain specified events, subject to applicable holding periods. The filing reports 75,781.26 shares beneficially owned following the reported transactions. The Form 4 was signed by an attorney-in-fact on 09/02/2025.
Daniel L. Florness, a director of H.B. Fuller Company (FUL), reported insider transactions dated 08/29/2025. The Form 4 discloses a disposition of 1,351 shares of common stock and the acquisition of 360.36 stock units under the Directors' Deferred Compensation Plan that convert 1-for-1 into common shares upon retirement, death, disability or certain events. The filing reports 28,794.88 shares beneficially owned following these transactions, which includes units received as dividend equivalents. The Form 4 was signed by an attorney-in-fact on 09/02/2025. All transactions are recorded as direct ownership.
H.B. Fuller Company (FUL) Executive VP & CFO John J. Corkrean reported changes in his beneficial ownership on Form 4. The filing shows a disposition of 52,196 shares of Common Stock on 08/15/2025. The report details derivative and equity holdings still held by the reporting person, including phantom units that convert 1-for-1 into common shares (159.84 units shown, representing 26,199.97 when combined with a dividend equivalent feature), multiple vested and unvested employee stock options with exercise prices ranging from $43.48 to $77.72 and individual option share counts listed (for example, 41,208, 48,309, 38,376 among others), and restricted stock units that vest in scheduled installments (examples: 1,292.02, 2,830.02, 4,335.92). The Form 4 is signed by an attorney-in-fact on behalf of the reporting person on 08/18/2025. The filing does not state a sale price for the 52,196-share disposition.
H.B. Fuller insider filing: Ms. Heather Campe, Senior Vice President, International Growth, reported transactions dated 08/15/2025. The filing shows a disposition of 22,316.23 shares of common stock in the non-derivative table. On the same date she acquired 36.77 phantom units that convert 1-for-1 into common stock under the company deferred compensation plan and acquired 36.77 underlying shares at an indicated price of $58.97. The report also lists multiple outstanding employee stock options (with strike prices $51.89, $53.57, $64.28, $68.17, $72.94, $77.72) and restricted stock units vesting over 2026–2028, with specific share amounts disclosed for each grant. The form is signed by an attorney-in-fact on 08/18/2025.
Joao Magalhaes, Sr. VP, Engineering Adhesives at H.B. Fuller (FUL), reported an employee option exercise and an offsetting share sale on 08/08/2025. He exercised 1,099 fully vested options with a $33.38 exercise price and sold 1,099 shares at $56.315. Following these transactions his direct beneficial ownership declined from 4,384 shares to 3,285 shares. Table II lists multiple outstanding option grants and restricted stock units, including an 8,853-share option at a $61.30 strike and RSU grants of 130.22, 301.33 and 1,562.29 shares (some RSUs include dividend-equivalent reinvestment). The Form 4 documents a routine exercise and sale and provides the current option and RSU holdings disclosed by the reporting person.
The Form 144 for H.B. Fuller Company reports a proposed sale of 1,099 common shares through Charles Schwab with an aggregate market value of $61,890, to be sold approximately on 08/08/2025 on the NYSE. The filing states these shares were acquired on 08/08/2025 via an employee stock option exercise, with payment described as a broker payment for cashless exercise.
The notice also discloses a recent sale of 1,046 shares on 08/07/2025 generating gross proceeds of $58,787. The signer represents they do not possess any undisclosed material adverse information. Several filer-identification fields in the provided text are blank.